317 related articles for article (PubMed ID: 25600367)
1. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
2. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
Olsen RW
Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
Whittemore ER; Yang W; Drewe JA; Woodward RM
Mol Pharmacol; 1996 Nov; 50(5):1364-75. PubMed ID: 8913369
[TBL] [Abstract][Full Text] [Related]
4. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between allosteric and orthosteric binding sites of γ-amino butyric acid type A receptors (GABA
Payghan PV; Nath Roy S; Bhattacharyya D; Ghoshal N
J Biomol Struct Dyn; 2019 Aug; 37(12):3065-3080. PubMed ID: 30608219
[TBL] [Abstract][Full Text] [Related]
6. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935
[TBL] [Abstract][Full Text] [Related]
7. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
[TBL] [Abstract][Full Text] [Related]
8. International Union of Basic and Clinical Pharmacology. CVI: GABA
Sieghart W; Savić MM
Pharmacol Rev; 2018 Oct; 70(4):836-878. PubMed ID: 30275042
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel positive allosteric modulators and null modulators at the GABAA receptor α+β- interface.
Varagic Z; Wimmer L; Schnürch M; Mihovilovic MD; Huang S; Rallapalli S; Cook JM; Mirheydari P; Ecker GF; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):371-83. PubMed ID: 23472852
[TBL] [Abstract][Full Text] [Related]
10. Modulating GABA modulators.
Paronis CA
Br J Pharmacol; 2006 Feb; 147(3):237-8. PubMed ID: 16331288
[TBL] [Abstract][Full Text] [Related]
11. GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites.
Sieghart W
Trends Pharmacol Sci; 1992 Dec; 13(12):446-50. PubMed ID: 1338138
[TBL] [Abstract][Full Text] [Related]
12. Regulation of allosteric coupling and function of stably expressed gamma-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists.
Klein RL; Mascia MP; Harkness PC; Hadingham KL; Whiting PJ; Harris RA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1484-92. PubMed ID: 7562525
[TBL] [Abstract][Full Text] [Related]
13. GABAA receptor partial agonists and antagonists: structure, binding mode, and pharmacology.
Krall J; Balle T; Krogsgaard-Larsen N; Sørensen TE; Krogsgaard-Larsen P; Kristiansen U; Frølund B
Adv Pharmacol; 2015; 72():201-27. PubMed ID: 25600372
[TBL] [Abstract][Full Text] [Related]
14. Orthosteric- versus allosteric-dependent activation of the GABA
Amin J; Subbarayan MS
Sci Rep; 2017 Aug; 7(1):7770. PubMed ID: 28798394
[TBL] [Abstract][Full Text] [Related]
15. Substituted pyrazinones, a new class of allosteric modulators for gamma-aminobutyric acidA receptors.
Im HK; Im WB; Judge TM; Gammill RB; Hamilton BJ; Carter DB; Pregenzer JF
Mol Pharmacol; 1993 Aug; 44(2):468-72. PubMed ID: 8018215
[TBL] [Abstract][Full Text] [Related]
16. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
17. The alpha5(H105R) mutation impairs alpha5 selective binding properties by altered positioning of the alpha5 subunit in GABAA receptors containing two distinct types of alpha subunits.
Balic E; Rudolph U; Fritschy JM; Mohler H; Benke D
J Neurochem; 2009 Jul; 110(1):244-54. PubMed ID: 19457072
[TBL] [Abstract][Full Text] [Related]
18. A Benzodiazepine Ligand with Improved GABA
Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for modulation of recombinant alpha1beta2gamma2 GABAA receptors by protons.
Huang RQ; Chen Z; Dillon GH
J Neurophysiol; 2004 Aug; 92(2):883-94. PubMed ID: 15028749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
